Authors:
Address: Patologia Medica, Azienda Ospedaliero-Universitaria Careggi Firenze, 50134 Florence, Italy.
Journal:

Publication:

abstract

phospholipases are produced from bacterial pathogens causing very different diseases. One of the most intriguing aspects of phospholipases is their potential to interfere with cellular signaling cascades and to modulate the host-immune response. Here, we investigated the role of the innate and acquired immune responses elicited by Chlamydophila pneumoniae phospholipase D (CpPLD) in the pathogenesis of atherosclerosis. We evaluated the cytokine and chemokine production induced by CpPLD in healthy donors' monocytes and in vivo activated T cells specific for CpPLD that infiltrate atherosclerotic lesions of patients with C. pneumoniae antibodies. We also examined the helper function of CpPLD-specific T cells for monocyte matrix metalloproteinase (MMP)-9 and tissue factor (TF) production as well as the CpPLD-induced chemokine expression by human venular endothelial cells (HUVECs). We report here that CpPLD is a TLR4 agonist able to induce the expression of IL-23, IL-6, IL-1β, TGF-β, and CCL-20 in monocytes, as well as CXCL-9, CCL-20, CCL-4, CCL-2, ICAM-1, and VCAM-1 in HUVECs. Plaque-derived T cells produce IL-17 in response to CpPLD. Moreover, CpPLD-specific CD4(+) T lymphocytes display helper function for monocyte MMP-9 and TF production. CpPLD promotes Th17 cell migration through the induction of chemokine secretion and adhesion molecule expression on endothelial cells. These findings indicate that CpPLD is able to drive the expression of IL-23, IL-6, IL-1β, TGF-β, and CCL-20 by monocytes and to elicit a Th17 immune response that plays a key role in the genesis of atherosclerosis.

Related Articles
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Thromb Haemost. 2006
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schömig A, May AE. Thromb Haemost. 2006 Jan; 95(1):151-8.
Characterization of the serological response to phospholipase D protein of Chlamydophila pneumoniae in patients with acute coronary syndromes.
Microbes Infect. 2009
Characterization of the serological response to phospholipase D protein of Chlamydophila pneumoniae in patients with acute coronary syndromes.
Mancini F, Savarino A, Losardo M, Cassone A, Ciervo A. Microbes Infect. 2009 Mar; 11(3):367-73. Epub 2009 Jan 31.
Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae.
Infect Immun. 2011
Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae.
Olliver M, Hiew J, Mellroth P, Henriques-Normark B, Bergman P. Infect Immun. 2011 Oct; 79(10):4210-7. Epub 2011 Jul 25.
Review Cooperation of liver cells in health and disease.
Adv Anat Embryol Cell Biol. 2001
Review Cooperation of liver cells in health and disease.
Kmieć Z. Adv Anat Embryol Cell Biol. 2001; 161:III-XIII, 1-151.
Review Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Innate Immun. 2008
Review Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H, Werdan K, Buerke M. Innate Immun. 2008 Apr; 14(2):63-87.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster